A
Andyrdj
http://www.corevalve.com/corevalve_press/02_16_2006.php
The above article relates to a patient who has had a failing bioprosthetic valve replaced using a percutaneous approach.
79 years old, very high risk patient unsuitable for ordinary surgery.
This is excellent news. Even if this particular individual doesn't enjoy that much extra life, it demonstrates it as a feasible alternative not just applicable to replacing native valves, and we should expect major advances in the future.
Very good news for those with tissue valves, perhaps even for the mech valvers, who of course aren't entirely immune from the need for replacement?
The above article relates to a patient who has had a failing bioprosthetic valve replaced using a percutaneous approach.
79 years old, very high risk patient unsuitable for ordinary surgery.
This is excellent news. Even if this particular individual doesn't enjoy that much extra life, it demonstrates it as a feasible alternative not just applicable to replacing native valves, and we should expect major advances in the future.
Very good news for those with tissue valves, perhaps even for the mech valvers, who of course aren't entirely immune from the need for replacement?
